Maxipime and Aranesp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxipime (cefepime hydrochloride) and Aranesp (darbepoetin alfa). Common drug interactions include atrial fibrillation among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Maxipime and Aranesp. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Maxipime?

Maxipime has active ingredients of cefepime hydrochloride. eHealthMe is studying from 4,279 Maxipime users. Check the latest studies of Maxipime.

What is Aranesp?

Aranesp has active ingredients of darbepoetin alfa. It is often used in anemia. eHealthMe is studying from 54,331 Aranesp users. Check the latest studies of Aranesp.

On Aug, 12, 2026

15 people who take Maxipime and Aranesp together, and have interactions are studied.

What are the common drug interactions of Maxipime and Aranesp, by gender? *:

female:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Thrombocytopenia (decrease of platelets in blood)
Anaemia (lack of blood)
Bacteraemia (presence of bacteria in the blood)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Diarrhoea
Enteritis (inflammation of the small intestine)
Hypokalaemia (low potassium)
Hypotension (abnormally low blood pressure)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

male:

Renal failure (kidney dysfunction)
Chronic kidney disease
Viral infection
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Pain

What are the common drug interactions of Maxipime and Aranesp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Renal failure (kidney dysfunction)
Anaemia (lack of blood)
Bacteraemia (presence of bacteria in the blood)
Blood calcium increased
Chronic kidney disease
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Nephrogenic anaemia (anaemia due to kidney disease)
Pyrexia (fever)
Viral infection

50-59:

Asthenia (weakness)
Diarrhoea
Enterocolonic fistula
Fatigue (feeling of tiredness)
Large intestine perforation (hole in large intestine)
Retroperitoneal abscess (a collection of pus between the peritoneum and the posterior abdominal wall. retroperitoneal. behind the peritoneum)
Urine output decreased

60+:

Pneumonia
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Neutropenia (an abnormally low number of neutrophils)
Renal failure (kidney dysfunction)
Urinary tract infection
Abdominal pain
Aortic calcification (aortic calcification sign of heart valve disease)
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Atelectasis (partial or complete collapse of the lung)

What are the existing conditions these people have? *

Headache (pain in head): 5 people, 33.33%
Multiple Myeloma (cancer of the plasma cells): 5 people, 33.33%
Anaemia (lack of blood): 3 people, 20.00%
Indigestion: 3 people, 20.00%
Blood Pressure Abnormal: 3 people, 20.00%
Diabetes: 3 people, 20.00%
Nephropathy (damage to or disease of a kidney): 3 people, 20.00%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 20.00%
Back Pain: 2 people, 13.33%
Bone Pain: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Maxipime and Aranesp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously